<?xml version="1.0" encoding="UTF-8"?>
<p id="Par62">Our study also has limitations. Firstly, considering this was a single-center, retrospective study with limited sample size, avoiding bias regarding patient distribution is considered difficult. Secondly, lymphopenia was observed in contribution to severe prognosis in this study, but data regarding CD4 and CD8 counts and other inflammatory biomarkers were not assessed; these biomarkers may also possibly associate with the patientsâ€™severe prognosis .</p>
